Surgalign Holdings, Inc.

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. Its products portfolio include cervical fixation, The Streamline (TL) fixation, motion preservation, orthobiologics, cervical inter-body fusion, TL IBF, and SI joint fusion. It offers coflex interlaminar stabilization device, SImmetry sacroiliac joint fusion system, and Fortilink IBF system with TETRAfuse?3D technology. The company was founded on February 12, 1998 and is headquartered in Deerfield, IL.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

RTI Surgical - OEM Business designs, develops, manufactures and distributes biologic, metal and synthetic implants for a global customer base. Its implants are used in a variety of surgical procedures including orthopaedic, spine, sports medicine, general surgery and trauma.

Surgalign Holdings, Inc. (SRGA) CEO Terry Rich on Q2 2021 Results - Earnings Call Transcript

Surgalign (SRGA) delivered earnings and revenue surprises of 25.00% and 1.26%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Surgalign Holdings (SRGA) Reports Q2 Loss, Tops Revenue Estimates

Shares of Surgalign Holdings (NASDAQ:SRGA) moved higher by 0.9% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 71.88% over the past year to ($0.09), which beat the estimate of ($0.12).

Recap: Surgalign Holdings Q2 Earnings

DEERFIELD, Ill., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today reported operating results for the second quarter of 2021.

Surgalign Holdings, Inc. Announces Second Quarter 2021 Results

Surgalign (SRGA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Surgalign Holdings (SRGA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

DEERFIELD, Ill., July 23, 2021 (GLOBE NEWSWIRE) -- Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced it plans to release financial results from the second quarter 2021 before the open of trading on Friday August 6, 2021.

Surgalign Holdings, Inc. Schedules Second Quarter 2021 Earnings Release for August 6, 2021

Surgalign raises $50M to continue operations throughout 2021 and beyond the FDA approval of the Holo Surgical platform (expected Q4 2021).

Surgalign Holdings: A Marketing Ploy

DEERFIELD, Ill., June 16, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that the management team will present at the Sidoti Virtual Investor Conference on Wednesday, June 23, 2021. The Company is scheduled to present at the conference at 2:30 p.m. Eastern Time the same day via webcast.

Surgalign Holdings, Inc. to Present at the Sidoti Virtual Investor Conference

DEERFIELD, Ill., June 14, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (“Surgalign”) (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that the closing of its previously announced registered direct offering for the issuance and sale of an aggregate of 28,985,508 shares of its common stock and warrants to purchase up to an aggregate of 28,985,508 shares of its common stock at a purchase price of $1.725 per share of common stock and related warrant. The warrants have an exercise price of $1.725 per share, will be immediately exercisable, and will expire three (3) years from the issuance date. The registered direct offering was priced at-the-market under Nasdaq rules.

Surgalign Holdings, Inc. Announces Closing of $50 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

DEERFIELD, Ill., June 07, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, and Inteneural Networks Inc., a developer of innovative artificial intelligence (AI) based applications focused on fully autonomous analytics of central nervous system imaging, today announced that they have entered into a strategic collaboration agreement. Under the agreement, Surgalign will gain access to Inteneural's proprietary technology for evaluation of future integration within the Surgalign digital surgery portfolio.

Surgalign Holdings Announces Collaboration with Inteneural Networks, a Leading Developer of Artificial Intelligence for Clinical Neurosciences

Chico's FAS

OrganiGram Holdings Inc.

With penny stocks in focus, which small-caps are you watching in June 2021? The post Best Penny Stocks to Buy in Summer 2021?

Best Penny Stocks to Buy in Summer 2021? Check These 3 Out

DEERFIELD, Ill., May 19, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that the management team will participate at the Craig-Hallum Institutional Investor Conference on Wednesday, June 2, 2021.

Surgalign Holdings, Inc. to Participate at the Craig-Hallum Institutional Investor Conference

Investors need to pay close attention to Surgalign Holdings (SRGA) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Surgalign Holdings (SRGA) Stock?

Surgalign Holdings, Inc. (SRGA) CEO Terry Rich on Q1 2021 Results - Earnings Call Transcript

Surgalign (SRGA) delivered earnings and revenue surprises of 0.00% and -1.06%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Surgalign Holdings (SRGA) Reports Q1 Loss, Misses Revenue Estimates

Shares of Surgalign Holdings (NASDAQ:SRGA) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 300.00% year over year to ($0.12), which beat the estimate of ($0.13).

Recap: Surgalign Holdings Q1 Earnings

DEERFIELD, Ill., May 10, 2021 (GLOBE NEWSWIRE) -- Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today reported operating results for the first quarter of 2021.

Surgalign Holdings, Inc. Announces First Quarter 2021 Results

Augmented Reality and Artificial Intelligence Technology Acquired Via Holo Surgical Acquisition Augmented Reality and Artificial Intelligence Technology Acquired Via Holo Surgical Acquisition

Surgalign Submits Premarket Notification 510(k) of Its Digital Surgical Guidance System

World-Class Machine Shop Broadens and Deepens Capabilities in Spine and Digital Surgery World-Class Machine Shop Broadens and Deepens Capabilities in Spine and Digital Surgery

Surgalign Adds Medical Device Prototyping and Manufacturing Facility in San Diego

DEERFIELD, Ill., May 03, 2021 (GLOBE NEWSWIRE) -- Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced it plans to release financial results from the first quarter 2021 after the close of trading on Monday May 10, 2021.

Surgalign Holdings, Inc. Schedules First Quarter 2021 Earnings Release for May 10, 2021

DEERFIELD, Ill., April 14, 2021 (GLOBE NEWSWIRE) -- Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced the appointment of Marc Mackey as Executive Vice President, Digital Surgery, effective immediately. In the newly created position reporting directly to Surgalign CEO Terry Rich, Mr. Mackey will lead the company's efforts to redefine and lead digital surgery.

Surgalign Appoints Marc Mackey as Executive Vice President, Digital Surgery

Curis

Pinduoduo Inc - ADR

One of the most common questions traders have about stocks is “Why Is It Moving?” That's why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro.

What's Happening With CRIS Stock, SRGA Stock And PDD Stock Wednesday?

Surgalign Holdings, Inc. (SRGA) CEO Terry Rich on Q4 2020 Earnings Conference Call Transcript

DEERFIELD, Ill., March 16, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, including through the application of digital technology, today reported operating results for the fourth quarter and full year 2020.

Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2020 Results and Introduces 2021 Guidance

DEERFIELD, Ill., March 05, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, including through the application of digital technology, today announced that it is changing its earnings release and conference call date for the fourth quarter and full year 2020 as a result of a delay completing the financial statements related to the sale of the OEM business and its classification as discontinued operations. The Company now plans to release financial results from the fourth quarter and full year 2020 on Tuesday, March 16, 2021, after the close of trading.

News for Surgalign Holdings, Inc. Stock (SRGA)